FDA advisors recommend Eli Lilly Alzheimer's drug donanemab
If approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind currently on the U.S. market after Leqembi from Biogen and Eisai.
Source: cnbc.com
David Risinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Risinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Risinger Today - Breaking & Trending Today
Novavax (briefly) becomes meme stock following Sanofi licensing deal
Novavax shares jumped 50% on Monday following its recent licensing deal with Sanofi, as meme stocks are making a 2021-style resurgence.
Source: mmm-online.com
The battle over the trillion-dollar weight-loss bonanza
Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?
Source: livemint.com
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024.
Source: yahoo.com
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024.
Source: fool.com